KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 83 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $72,357,000 | -19.3% | 965,015 | -18.9% | 0.02% | -9.5% |
| Q2 2015 | $89,623,000 | +63.0% | 1,190,053 | +8.5% | 0.02% | +61.5% |
| Q1 2015 | $54,987,000 | +60.1% | 1,096,458 | +10.7% | 0.01% | +62.5% |
| Q4 2014 | $34,344,000 | +19.0% | 990,320 | +12.4% | 0.01% | 0.0% |
| Q3 2014 | $28,858,000 | -11.9% | 880,896 | +3.1% | 0.01% | -11.1% |
| Q2 2014 | $32,770,000 | +16.9% | 854,064 | +21.1% | 0.01% | +12.5% |
| Q1 2014 | $28,036,000 | +32.8% | 705,140 | +24.8% | 0.01% | +33.3% |
| Q4 2013 | $21,109,000 | +61.2% | 565,171 | +96.8% | 0.01% | +50.0% |
| Q3 2013 | $13,092,000 | +90.7% | 287,184 | +13.1% | 0.00% | +33.3% |
| Q2 2013 | $6,867,000 | – | 253,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,668,000 | 4.13% |
| Versant Venture Management, LLC | 70,376 | $2,440,640,000 | 2.33% |
| Palo Alto Investors LP | 1,121,884 | $38,907,000 | 2.28% |
| Aureus Asset Management, LLC | 124,087 | $4,303,000 | 1.05% |
| PFM Health Sciences, LP | 1,085,315 | $37,639,000 | 0.88% |
| HARBOURVEST PARTNERS LLC | 39,318 | $1,364,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,119,425,000 | 0.52% |
| Partner Investment Management, L.P. | 24,456 | $848,000 | 0.35% |
| Old West Investment Management, LLC | 15,162 | $525,000 | 0.32% |
| Polar Capital LLP | 405,544 | $14,063,000 | 0.27% |